Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03484065 · ClinicalTrials.gov registry record
Quality of Life in Patients With Congenital Afibrinogenemia
A clinical trial, sponsored by University Hospital, Geneva.
- Completed
- Registry status
- 250
- Enrollment target
NCT03484065 is a clinical trial that has completed, run by University Hospital, Geneva. The registered enrollment target is 250 participants.
The verdict
NCT03484065 has completed, sponsored by University Hospital, Geneva.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The aim of this observational study is to evaluate the quality of life in patients with congenital afibrinogenemia using the Haemo-QoL SF for kids and the Haem-A-QoL for adult patients.
Interventions
- OTHER Questionnaire quality of life
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2016-06 |
| Est. Completion | 2020-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03484065
The ClinicalTrials.gov registry entry for NCT03484065 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospital, Geneva, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire quality of life is the first listed.
NCT03484065 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03484065 about?
NCT03484065 is a clinical study titled "Quality of Life in Patients With Congenital Afibrinogenemia". The aim of this observational study is to evaluate the quality of life in patients with congenital afibrinogenemia using the Haemo-QoL SF for kids and the Haem-A-QoL for adult patients.
What is the current status of trial NCT03484065?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2016-06. Estimated completion is 2020-06.
What interventions are being tested in trial NCT03484065?
The interventions under investigation include: Questionnaire quality of life (OTHER).
Who is sponsoring clinical trial NCT03484065?
This trial is sponsored by University Hospital, Geneva, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.